Seres Therapeutics (VOWST Business) Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Seres Therapeutics (VOWST Business) General Information

Description

Developer of microbiome therapeutics intended to prevent the recurrence of Clostridioides difficile infection. The company intends to develop new therapeutics for populations known to harbor disrupted gastrointestinal microbiomes or compromised immune systems, who are at high risk of serious, life-threatening bacterial infections that are costly to healthcare systems.

Contact Information

Website
www.vowst.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 121 River Street
  • Hoboken, NJ 07030
  • United States
+1 (888)
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Parent Company
Corporate Office
  • 121 River Street
  • Hoboken, NJ 07030
  • United States
+1 (888)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Seres Therapeutics (VOWST Business) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Seres Therapeutics (VOWST Business)‘s full profile, request access.

Request a free trial

Seres Therapeutics (VOWST Business) Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of microbiome therapeutics intended to prevent the recurrence of Clostridioides difficile infection. The compa
Drug Discovery
Hoboken, NJ

Wilmington, DE
 

San Rafael, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Seres Therapeutics (VOWST Business) Competitors (59)

One of Seres Therapeutics (VOWST Business)’s 59 competitors is Bugworks Research, a Private Equity-Backed company based in Wilmington, DE.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Bugworks Research Private Equity-Backed Wilmington, DE
BioMarin Pharmaceutical Formerly PE-Backed San Rafael, CA
MC2 Therapeutics Corporation Horsholm, Denmark
F2G Venture Capital-Backed Macclesfield, United Kingdom
Scynexis Formerly VC-backed Jersey City, NJ
You’re viewing 5 of 59 competitors. Get the full list »

Seres Therapeutics (VOWST Business) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Seres Therapeutics (VOWST Business)‘s full profile, request access.

Request a free trial

Seres Therapeutics (VOWST Business) FAQs

  • When was Seres Therapeutics (VOWST Business) founded?

    Seres Therapeutics (VOWST Business) was founded in 2023.

  • Where is Seres Therapeutics (VOWST Business) headquartered?

    Seres Therapeutics (VOWST Business) is headquartered in Hoboken, NJ.

  • What industry is Seres Therapeutics (VOWST Business) in?

    Seres Therapeutics (VOWST Business)’s primary industry is Drug Discovery.

  • Is Seres Therapeutics (VOWST Business) a private or public company?

    Seres Therapeutics (VOWST Business) is a Private company.

  • What is the current valuation of Seres Therapeutics (VOWST Business)?

    The current valuation of Seres Therapeutics (VOWST Business) is .

  • What is Seres Therapeutics (VOWST Business)’s current revenue?

    The current revenue for Seres Therapeutics (VOWST Business) is .

  • Who are Seres Therapeutics (VOWST Business)’s investors?

    Seres Therapeutics has invested in Seres Therapeutics (VOWST Business).

  • Who are Seres Therapeutics (VOWST Business)’s competitors?

    Bugworks Research, BioMarin Pharmaceutical, MC2 Therapeutics, F2G, and Scynexis are some of the 59 competitors of Seres Therapeutics (VOWST Business).

  • When was Seres Therapeutics (VOWST Business) acquired?

    Seres Therapeutics (VOWST Business) was acquired on 30-Sep-2024.

  • Who acquired Seres Therapeutics (VOWST Business)?

    Seres Therapeutics (VOWST Business) was acquired by Nestlé Health Science.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process